Closing the missing link between childhood risk factors and adult cardiovascular outcomes
Prescient childhood cohort studies launched in the 1970s are paying off.
* * *
Help us make this podcast better! Please take our short listener survey: https://www.surveymonkey.com/r/podcastsurveyOct2019
* * *
Metabolic signs of adult diabetes apparent in very young children
Disturbed HDL cholesterol metabolism may be one of the earliest features of type 2 diabetes.
Sacubitril/valsartan suggests HFpEF benefit in neutral PARAGON-HF
The primary endpoint was neutral, but desperation for a HFpEF therapy highlights a subgroup analysis.
* * *
For more MDedge Podcasts, go to mdedge.com/podcasts
Email the show: podcasts@mdedge.com
Interact with us on Twitter: @MDedgeTweets
PCI reduces mortality after STEMI in older adults
Alirocumab reduces MIs
Too much hype for radial access PCI?
Ticagrelor reversal and certification changes
Top News from ACC 19
New LDL-lowering drug is under FDA review
Forget what you learned about infective endocarditis
A weight-loss drug is poised for expanded indication
Who is least adherent to statins, and more
What comes first with SGLT2 inhibitors – diabetes or heart failure?
'Simple' way to cut PAD risk, misguided ED visits for atrial fib, and more
Atrial fib guidelines updated, SPRINT MIND published, and more
FDA: Benefits still outweigh risks from paclitaxel-coated devices for PAD
Sleep: Too much, too little both tied to atherosclerosis
Biodegradable stent polymer offers no long-term protection
Reducing heart failure readmissions raises mortality
Societies refresh diabetes and PAD guidance
AHA statement on statin risks, app that diagnoses STEMI, and more
Withdrawing heart failure meds, the best DOAC for octogenarians, and more
AHA jewels, readmissions not best at 'Best Hospitals,' and more
Create your
podcast in
minutes
It is Free
Good Mood Revolution
Good Nurse Bad Nurse
The Relaxback UK Show
On Call With Dr. Anselm Anyoha
The Doctor’s Farmacy with Mark Hyman, M.D.
The Peter Attia Drive